Email

mayver.gonzalezvargas@bcm.edu

Positions

Research Coordinator II

Pediatrics - Nutrition
Baylor College of Medicine

Research Assistant Volunteer

Liver Associates of Texas P.A
Houston, Texas United States

Addresses

Children Nutrition Research Center (Lab) (Office)

1100 BATES ST
room 10053
Houston, TX 77030
United States
Phone: (718) 798-7124
Fax: (713) 798-7098
mayver.gonzalezvargas@bcm.edu
https://www.bcm.edu/people-search/mayver-gonzalez-vargas-119366

Education

MD from University of Zulia

06/2013 - Maracaibo, Zulia Venezuela

Certifications

Medical Doctor

ECFMG

Basic Support Life

AHA

Honors & Awards

Medical Doctor

ECFMG certified (08/2022)

Professional Statement

Humble, team worker, leader, passionate about science and clinical research.
Interested in Obesity, GI diseases as PBC, NASH, PSC, HCC and cirrhosis of the liver.
International Medical Graduate Mentor, I am passionate about Latin culture inclusion.

Projects

Genetic Disorders of Obesity Program (CGDO

(04/2021 - present)

This project is for collecting information on all children who come into the CGDO clinic. The aim is to use this information to determine better strategies for identifying children who would benefit from genetic testing, how children respond to therapies, and how to better support parents. This project also includes collecting cheek swabs of children and their parents for genetic analysis by future studies.

Setmelanotide Phase 2 and Phase 3 Treatment Trials in Patients with Rare Genetic Disorders of Obesity

(08/2020 - present)

This project is several clinical trials that have a purpose to determine the effect of setmelanotide (RM-493) on weight, hunger assessments, and other factors in patients with rare genetic disorders of obesity. • RM-493-014; Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients with Rare Genetic Disorders of Obesity (currently closed for enrollment) • RM-493-022; Long-Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated with Genetic Defects Upstream of the MC4 Receptor in the Leptin-Melanocortin Pathway (open) • RM-4930-034; A 2-Stage (Open-Label Run-in followed by Randomized Withdrawal), Double-Blind, Placebo-Controlled, Phase 2 Study of Setmelanotide in Patients with Specific Gene Defects in the Melanocortin-4 Receptor Pathway (will open soon) • RM-493-035; A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study: 5 Independent Sub-studies of Setmelanotide in Patients with POMC, PCSK1, LEPR, SRC1, SH2B1, and PCSK1 N221D Gene Defects in the Melanocortin-4 Receptor Pathway (will open soon)

Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Adolescent Bariatrics: Assessing Health Benefits and Risk (Teen-LABS)

(08/2020 - present)

This project is to assess the short and longer-term safety and efficacy of bariatric surgery in adolescents compared to adults, our site is one of the five Teen-LABS clinical centers nationwide.

Memberships

MOLA

Mentor (09/2022)

American Medical Women Association

IMG committee (01/2021)

American Medical Association

(09/2022)

AAFP

member (05/2022)

Languages

Spanish, Italian, French